chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/14/03 Hives--2 p.m.--bedtime. 1/14/03 Fever--in a.m. when awake 101 degrees F axillary.  Tylenol (3 tabs q. 4 hours while awake--children's dosage).  Benadryl x 1 for hives--resolved 1/15/03.
Headache, nausea 8-12 hours after shot Rash/swelling at the injection site 15 hours after the injection.
J96.00 ACUTE RESPIRATORY FAILURE 8/8/2021 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART J96.00 ACUTE RESPIRATORY FAILURE 8/8/2021 HYPONATREMIA
Pt recvd 1st dose of Engerix-B 3OCT90 & exp inject site pain which radiated to rotation cuff of the shoulder; Pt seen by surgeon who felt had either sterile abscess or rxn to vax; pt lost ROM in lt arm &is in PT; Recvd 2 addtl doses of vax;
This case was reported by a healthcare professional and described the occurrence of strange taste in a 25-year-old male subject who was vaccinated with ENGERIX B, (GlaxoSmithKline).  There were no concurrent medications.  On 24 January 2008 at 09:30 the subject received 1st dose of ENGERIX B at 20 mcg.  On 24 January 2008, 20 to 30 minutes after vaccination with ENGERIX B, the subject experienced a strange taste in his mouth which resolved (end date 24 January 2008).  The subject experienced no allergy like symptoms.
FDA and CDC rescinded their authorization for booster dossing (12 and over) Pfizer .
Low grade fever in the 99 range, a little fussy, showed bruises days after vaccines within the week was diagnosed with ITP, been almost a year now. No treatment.
Right deltoid - red and swollen and painful gave BENADRYL and MOTRIN treating with KEFLEX and MOTRIN and BENADRYL.
This spontaneous report was received from a Registered Nurse concerning a patient of unknown age or gender. The patient's concurrent conditions, medical history or allergy/drug reactions were not reported. On 01-APR-2016, the patient was vaccinated with an expired dose of RECOMBIVAX HB 10 micrograms, 1 ml, via intramuscular, lot # K002327, exp.: 07-FEB-2016. There was no concomitant medications reported. No adverse effects were reported. Additional information has been requested.
Pt had syncope episode, turn pale and fainted, oxygen was given and was monitor for 30 minutes in the office.
2 minutes after administering HPV 31, patient became pale, diaphoretic, dizzy, reaction complete syncope, anxious state x 1-2 minutes. Recovered in 15 minutes to discharge; Near fainting
All of my teeth ache whenever drinking hot coffee. This symptom has persisted for the past 7 months. Severity has subsided somewhat but is still quite bothersome. (My therapist related that she experienced the same symptom.)
Nonspecific toe discomfort ,mainly middle toe left foot noticed several days (5-7) later, Suspected infection and made Tele visit appointment with primary MD ,who pointed out toes even redder on right foot ,mainly affecting middle and second toes of both feet altho extreme discomfort only middle toe L foot. Doctor believes it is Covid toe vaccine side effect from booster, which I had 17 days ago
viral pneumonia; wheezing; coughing; fever; This serious case was reported by a nurse via sales rep and described the occurrence of viral pneumonia in a 89-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Concomitant products included COVID-19 VACCINE (COVID VACCINE).   On an unknown date, the patient received Arexvy. On an unknown date, 24 hrs after receiving Arexvy, the patient experienced viral pneumonia (Verbatim: viral pneumonia) (serious criteria GSK medically significant), wheezing (Verbatim: wheezing), cough (Verbatim: coughing) and fever (Verbatim: fever). The patient was treated with antibiotics nos (Antibiotic (Active Ingredient Unknown)) and steroids nos (Steroids). The outcome of the viral pneumonia, wheezing, cough and fever were unknown.   It was unknown if the reporter considered the viral pneumonia, wheezing, cough and fever to be related to Arexvy.     It was unknown if the company considered the viral pneumonia, wheezing, cough and fever to be related to Arexvy.   Additional Information: GSK Receipt Date: 19-OCT-2023 Reporter reported that the patient received Covid vaccine and 5 days later she received the Arexvy vaccine. 24 hours after receiving Arexvy vaccine, the patient experienced fever, coughing, wheezing and viral pneumonia. The patient was treated with an antibiotic and steroid. The reporter consented to follow up.
I needed up get the Pfizer vaccine on Dec 23, 2020 since I worked in a Long Term Care Facility in a remote village and was scheduled to receive the next vaccine on Jan 6, 2021. However, I was released from my job on Jan 1, 2021. On Jan 4th, 2021, I was flown to another city. I spent some time there. Then, on Jan 16th, 2021, I landed in another city and checked in to a hotel. The next day, I was tested for the Corona Virus via nasal swab. The following day, they called me and said my test came back positive and said I had to quarantine for 10 days. I had minor pneumonia symptoms, but I felt they were not bad enough for me to go to the hospital. My symptoms were gone in about 5 days. I left being quarantine on Jan 30th, 2021.
No adverse events reported. Vaccine was not reconstituted with correct volume of diluent. Only 0.8ml was used instead of 1.8ml
Patient passed out approximately 5 minutes after receiving covid-19 first dose vaccine. Mother alerted pharmacy staff. Pharmacist went out to provide assistance and 911 was called. Patient was alert and responsive. Urgent care doctor from next door arrived to provide assistance. Patient laid down on the ground until paramedics arrived. We got patient water, Gatorade and neck rest to make him comfortable. While the patient was awake and responsive, he turned pale but no cpr or epi-pen were needed. Paramedics took patient with them after event. Patient was fine during administration of the vaccine and walked out with no problems or questions.
Chest pain since 12/25/2020 (no treatment, written off as anxiety), flare of bursitis since 12/25/2020 (solumedrol injections from rheumatologist in right knee and both shoulders), tingling in fingers, toes, & lips since 12/25/2020 (no treatment), psoriasis flare of face since 12/25/2020 (never experienced before reaching out to dermatologist) Low grade fever off and on 12/31/2020 until 1/11/2021
Patient states that his arm swelled past the injection site, down to his lower arm. Patient described the swelling as painful and "as large as his leg".
A 40-year-old female patient experienced leg weakness, achiness, increased tiredness, fever, pain in her back, neck and head after receiving RabAvert. The patient received one dose of RabAvert, 1 ml intramuscularly, on 25 Sep 03. She had previously received one dose of human rabies immunoglobin (HRIG) and Imovax for her first post-exposure dose on 12 Sep 03. Concomitant medications included Diovan HCT, Allegra, Rhinocort, Flovent, and Xanax. The patient's medical history included eczema, severe allergies to unspecified agents and current sinus infection for which she was receiving amoxicillin.  On 12 Sep 03 the patient received her first dose of HRIG and Imovax for post exposure treatment. Due to symptoms of headache and tiredness after HRIG and Imovax administration, the patient was switched to RabAvert per her physician. She received her first dose of RabAvert on 25 Sep 03, after which she complained of leg weakness, achiness, and neck, lumbar, and head pain described as shooting, intermittent pains and twinges in the back of her head. She also complained that she was feeling feverish and was more tired that usual. She reported that she experienced similar side effects after her first injection of Imovax.  Follow-up information received on 06 Oct 03: The reporter (patient) was contacted via telephone and provided the following information. She was receiving the post-exposure series because of a "possible" secondary exposure to rabies. She had gotten saliva from and unknown animal in her eye while she was chasing her cat, and subsequently informed her physician who thought she should start the rabies series. During this time she called the Center for Disease Control (CDC) to ask about her symptoms. The CDC physician told her that she did not consider the patient to be "exposed" per the case details and should not probably be receiving rabies treatment. The patient communicated this to her physician who decided to stop the post-exposure series based her discussion with the CDC. The patient's physician was going to contact the physician at the CDC to follow-up. She had not received any additional doses of RabAvert other than the one dose.   The patient's worse remaining symptom was the intermittent shooting pain/twinges in the back of her head and neck. She also described "awful headaches." She was no longer taking antibiotics for the sinus infection, though her physician said she was still "swollen" and put her on Allegra D. The patient has had swollen eyes in the past from animal exposures. Her physician did blood work on her after the symptoms started and the blood work came back "ok". She may follow-up with a neurologist if her physician feels that she should.
Abdominal pain and distention 48 hours after injection,   w/o nausea or vomiting.   Symptoms moderate.
patient complained several weeks after receiving second dose in right arm that she is still sore. patient thinks it was given too high.
Patient stated that she had heart attack symptoms, chest pain, shortness of breath, tingling pain in left arm, lightheadness.  Patient went the the ER and the doctor there concluded it was carditis from an interaction between the 1st modrena covid vaccine and her birth control estarylla.  Dr there also told her she could have a heart attack if she got the 2nd moderna vaccine but advised her to get it anyways.  Patient went back for a followup and a different dr told her to get the 2nd moderna vaccine aas well but her heart was ok and no issues with it.  Pharmacist told her to get another opinion as to wether she should get another covid vaccine and if she did to get it in a healthcare setting that could take care of her if she had a heart attack or other reaction.  Patient went to Hospital emergency department.  Pharmacist did not feel comfortable giving patient 2nd moderna shot at this location due to the risk of a heart attack.
PT. RECEIVED JANSSEN COVID VACCINE AFTER RECEIVING FIRST AND SECOND DOSE OF MODERNA VACCINE
This spontaneous report as received from a 65 year old female patient. The patient had no pertinent medical history and no drug reactions/allergies. On 10-APR-2013 the patient was vaccinated with one time dose of ZOSTAVAX (lot # not reported), subcutaneously into the back side of the left arm. Concomitant medications included unspecified high blood pressure medication. On 12-APR-2013, the patient experienced redness at the site of insertion on the left arm. The outcome of the event is unknown. No laboratory test was performed. The patient did not seek medical attention. Additional information has been requested.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies were reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB for prophylaxis (lot number L044707, expiration date 06-OCT-2018; dose and route of administration were not reported). Administered doses of vaccines experienced the following temperature excursions: on 15-DEC-2016 of 11 degrees Celsius for 4 hours 13 minutes, on 16-DEC-2016 of 11 degrees Celsius for 9 hours 20 minutes, on 29-DEC-2016 of 11 degrees Celsius for 3 hours 37 minutes, a total  temperature excursion was 17 hours 10 minutes cumulative hours in more than 8 degrees Celsius and less than 25 degrees Celsius. Data logger was involved. There was no adverse effect reported. This is one of several reports received from the same reporter.Additional information has been requested.; Sender's Comments: US-009507513-1701USA005206: US-009507513-1701USA005205: US-009507513-1701USA001537:
Fast pulse/really fast pulse; Shaking really bad; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills). At the time of the report, HEART RATE INCREASED (Fast pulse/really fast pulse), TREMOR (Shaking really bad) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported.  Treatment medication was not reported.
* 1-3 days after vaccine: Extreme arm and muscle soreness at and around injection site on left arm. * 1 week after injection: red puffy rash, about 2in by 2in, at injection sight. Very warm patch and itchy. Also itchiness on back area.
Headache, Myalgia, Fever & Palpitations Narrative: day 1- injection site pain. day 2-3 fever, chills, HA, swollen glands,  achy joints, pain up into neck and under arms. Chest pain, hot flashes and  impending sense of doom. Did not seek any medical attention for these  symptoms.
Myalgias, joint aches, nausea, severe rigors and chills starting about 12 hours after administration of vaccine
Please NOTE:   The adverse reactions began with the first dosage on 1/31/21                                      that was Moderna / lot 007M20A / same location as the  second dose listed above.                                     Your format is not set-up to put two shot information well. So:  on 1/31/2021 my wife received her first COVID-19 shot.  a week after the injection she developed a                                     large red rash at the injection site about 3 inches in diameter...it lasted a few days and                                      dissipated.           On  2/28/2021 my wife received her second  COVID-19 shot.  the evening of that vaccine                                       she developed severe muscle aches and  a very bad eye infection that swelled and itched.                                       we are a week out and the symptoms ar just now beginning to subside.
This is a spontaneous report received from contactable consumer (patient). A 73-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6202), at the age of 73, in right arm, on Feb 26, 2021, at 10:45, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. The patient had pain in extremity (her arm was sore), onset Feb 26, 2021, with outcome of recovered (Feb 28, 2021). No follow-up attempts possible. No further information expected.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 69-year-old male patient who received SHINGRIX (batch number ML532, expiry date 13th July 2020) for prophylaxis. On 29th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 29th May 2018, 2 hrs after receiving SHINGRIX, the patient experienced fever, malaise and muscle pain. On an unknown date, the outcome of the fever, malaise and muscle pain were recovered/resolved. It was unknown if the reporter considered the fever, malaise and muscle pain to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the registered pharmacist (Rph). The patient received SHINGRIX in left arm. The events resolved after about 1 day. This case was linked with the case US2018147988, reported by the same reporter. The reported batch number M1532 for SHINGRIX does not exist in sales database and was updated as ML532 as per sales database.
BLEEDING OF THE GUMS; NOSEBLEED FOR 3 DAYS; CUT THAT WOULDN'T STOP BLEEDING; CHANGE IN TASTE (PEANUT BUTTER DIDN'T TASTE THE SAME); This spontaneous report received from a patient concerned a 46 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 01-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-JUN-2021, the patient experienced bleeding of the gums. On 01-JUN-2021, the patient experienced nosebleed for 3 days. On 01-JUN-2021, the patient experienced cut that wouldn't stop bleeding. On 01-JUN-2021, the patient experienced change in taste (peanut butter didn't taste the same). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bleeding of the gums, and change in taste (peanut butter didn't taste the same) on 29-JUN-2021, nosebleed for 3 days on 03-JUN-2021, and cut that wouldn't stop bleeding on 02-JUN-2021. This report was non-serious.
Only side effect of first vaccine was sore arm for a few days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Mar2021 10:00 (Batch/Lot number: unknown) at the age of 59 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies" (unspecified if ongoing), notes: Allergies to other products: demoral; "Allergies to medications" (unspecified if ongoing), notes: Allergies to medications; "food allergy" (unspecified if ongoing), notes: Allergies to food. Concomitant medication(s) included: TYLENOL; ZOLOFT. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 11Apr2021, outcome "recovered" (Apr2021), described as "Only side effect of first vaccine was sore arm for a few days". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: The patient had not received any other vaccine within 4 weeks. Pregnant at the time of vaccination was no. List of any other medications the patient received within 2 weeks of vaccination: multi-vitamin, tylenol, Zoloft. Reported Event: Only side effect of first vaccine was sore arm for a few days. After second vaccine only side effect was sore breasts/lymph nodes on left side (opposite of the side she got the shot on) days 4-6 after shot. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Allergies to medications, food, or other products: demoral. Vaccine Facility information available. Race information was available. Location of injection information was available for all vaccines received on the same date. No treatment received for the adverse event.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on left arm, below the injection site. Rash appeared 2 days post vaccination.   Rash is red, warm to the touch, and itchy.
Information has been received from a physician concerning a female patient who was vaccinated with GARDASIL. Subsequently the patient experienced syncope. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. Additional information has been received from an other health professional indicated that she could not fill out the form because she couldn't find the patient and the physician was no longer worked in the office. She would not return the form to Merck. Additional information is not expected.
pt recvd 1st dose of Hep B vax on 3AUG92; On 27AUG92 pt devel flat punctate pruritic rash on arms, thighs, & stomach;
That evening I had pain in my shoulder and up my neck into my head and a low grade fever. The next day my arm was all red and swollen by the end of the day it was a major rash on my arm and down the backside of my arm and my shoulder. I also had congestion in my nose and still have the congestion and the rash
t101 fever started few hr p/vax together w/diarrhea, progressively worse for 10 days developing into vomiting & anorexia (both for food & liquids) & beginning dehydration;
Narrative: Symptoms:  SkinRash, Rash & UrticariaPruritus Treatment:  DIPHENHYDRAMINE 25mg to 50mg TAB QID
pretty sick from the last vaccine; felt kind of queasy after the first dose; like having a bad case of the flu for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like having a bad case of the flu for 24 hours), ILLNESS (pretty sick from the last vaccine) and NAUSEA (felt kind of queasy after the first dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 089A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like having a bad case of the flu for 24 hours), ILLNESS (pretty sick from the last vaccine) and NAUSEA (felt kind of queasy after the first dose). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (like having a bad case of the flu for 24 hours) had resolved and ILLNESS (pretty sick from the last vaccine) and NAUSEA (felt kind of queasy after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-370441 (Patient Link).
Redness, swelling Rt upper arm 1 d after vaccines administered. Symptoms treated with antibiotics for possible cellulitis.
Symptoms began as achiness then progressed to muscle cramps, then weakness, especially in extremities; fatigue. Symptoms worsened and peaked on 10/30/02. 10/31/02 symptoms began to dissipate. Treatment involved Ibuprofen QID, Braxin, Tylenol.
Breakthrough case admission after 1 Janssen vaccine Janssen 5/13/21 Lot# 203A21A
Patient was noted to be seizing (T-C movements, eyes rolling) x 1 1/2 minutes. He turned blue. He remained stiff in his upper extremities for several minutes after the seizure. He was transported to the ER by EMS. No further seizure activity during the hospitalization. Fever to 103 lasted for 2 days. Rash developed on chest and abdomen on 11/1.
Patient suddnely felt very fatigued, somewhat "cold."  She went to bed, woke up feeling "shaky," got up to go to the bathroom, felt "light headed", had a temperature of 99.7.  Her back hurt and she had a headache.